UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000010726
Receipt number R000012536
Scientific Title The effect of microemulsion propofol as an induction drug on the withdrawal response associated with an injection of rocuronium
Date of disclosure of the study information 2013/05/15
Last modified on 2022/11/21 14:25:52

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effect of microemulsion propofol as an induction drug on the withdrawal response associated with an injection of rocuronium

Acronym

microemulsion propofol and rocuronium withdrawal

Scientific Title

The effect of microemulsion propofol as an induction drug on the withdrawal response associated with an injection of rocuronium

Scientific Title:Acronym

microemulsion propofol and rocuronium withdrawal

Region

Asia(except Japan)


Condition

Condition

elective surgery

Classification by specialty

Anesthesiology Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

reduce the frequency and severity of pain during an injection of rocuronium

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

the withdrawal movement on injection of rocuronium could be attenuated by microemulsion propofol as an anesthetic induction agent.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Prevention

Type of intervention

Other

Interventions/Control_1

microemulsion propofol injection. observe withdrawal response of hand or are during injection, for few seconds

Interventions/Control_2

long-chain triglyceride emulsion propofol

Interventions/Control_3

active control group for anesthetic induction, conventional intravenous barbiturate,thiopental

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <

Age-upper limit

54 years-old >

Gender

Male and Female

Key inclusion criteria

ASA (The American Society of Anesthesiologists) physical status 1 who were scheduled for elective surgery

Key exclusion criteria

Patients with a known allergy to propofol or thiopental, a history of seizures, cardiovascular defects, respiratory defects, renal insufficiency, hepatic impairment, a hypovolemic state, pregnancy or who were being treated with analgesics were excluded.

Target sample size

120


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Il-Ok Lee

Organization

Korea University

Division name

Anesthesiology and Pain Medicine

Zip code


Address

Gurodong-ro 148, guro-gu, Seoul, Korea

TEL

82-2-2626-1437

Email

iloklee@korea.ac.kr


Public contact

Name of contact person

1st name
Middle name
Last name Il-Ok Lee

Organization

Korea University

Division name

Anesthesiology and Pain Medicine

Zip code


Address

gurodong-ro 148, guro-ku, Seoul, Republic of korea

TEL

82-2-2626-1437

Homepage URL


Email

iloklee@korea.ac.kr


Sponsor or person

Institute

Korea University

Institute

Department

Personal name



Funding Source

Organization

Korea University

Organization

Division

Category of Funding Organization

Outside Japan

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2013 Year 05 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2013 Year 05 Month 20 Day

Date of IRB

2013 Year 05 Month 20 Day

Anticipated trial start date

2013 Year 05 Month 20 Day

Last follow-up date

2016 Year 11 Month 16 Day

Date of closure to data entry

2016 Year 11 Month 16 Day

Date trial data considered complete

2016 Year 11 Month 16 Day

Date analysis concluded

2016 Year 11 Month 16 Day


Other

Other related information



Management information

Registered date

2013 Year 05 Month 15 Day

Last modified on

2022 Year 11 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012536


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name